Tango Therapeutics Inc

The current institutional shareholding score of Tango Therapeutics Inc is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 123.32%, representing a quarter-over-quarter increase of 24.30%. The largest institutional shareholder is Steven Cohen, holding a total of 568.45K shares, representing 0.37% of shares outstanding, with 12.50% increase in holdings.